
Axcynsis Therapeutics
Developer of antibody-drug conjugate therapies designed for treating cancer. The company's platform leverages proprietary technologies to create antibody-toxin conjugates, enabling healthcare companie...
Valuation
$36.1M
Latest known
Share Price
N/A
Total Raised
$21M
Last Round
N/A